Evaluation of a novel blood microsampling device for clinical trial sample collection and protein biomarker analysis.
Bioanalysis
; 12(13): 919-935, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: covidwho-656243
ABSTRACT
Aim:
Evaluation of a novel microsampling device for its use in clinical sample collection and biomarker analysis.Methodology:
Matching samples were collected from 16 healthy donors (ten females, six males; age 42 ± 20) via K2EDTA touch activated phlebotomy (TAP) device and phlebotomy. The protein profile differences between sampling groups was evaluated using aptamer-based proteomic assay SomaScan and selected ELISA.Conclusion:
Somascan signal concordance between phlebotomy- and TAP-generated samples was studied and comparability of protein abundances between these blood sample collection methods was demonstrated. Statistically significant correlation in selected ELISA assays also confirmed the TAP device applicability to the quantitative analysis of protein biomarkers in clinical trials.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Proteínas Sanguíneas
/
Flebotomía
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
/
Middle aged
/
Young_adult
Idioma:
Inglés
Revista:
Bioanalysis
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Bio-2020-0063
Similares
MEDLINE
...
LILACS
LIS